Table 5.

Predictors of tixagevimab/cilgavimab administration among people who consented

	Unadjusted OR (95% CI; p value)	Adjusted OR (95% CI; p value)
Assigned administration centre
Local supercare pharmacy	1.00	1.00
Hospital infusion centre	1.13 (0.98 to 1.31; 0.097)	3.09 (1.08 to 9.94; 0.044)
Vaccination hub	0.94 (0.82 to 1.07; 0.338)	0.82 (0.36 to 1.81; 0.622)
Number of prior COVID-19 vaccinations	1.11 (1.04 to 1.19; 0.002)	1.86 (1.20 to 2.94; 0.006)

Additional covariates adjusted for in multivariable model were age, sex, EDSS score and prior COVID-19.

EDSS, Expanded Disability Status Scale.